| 期 |
栏目 |
标题 |
文件 |
| 卷 82, 编号 4 (2010) |
Editorial |
Tissue myocardial Doppler echocardiographic evaluation of right heart function and the level natriuretic peptides in patients with pulmonary hypertension of various etiologies |
|
| 卷 82, 编号 11 (2010) |
Editorial |
Use of a nonselective endothelin receptor antagonist in idiopathic pulmonary hypertension |
|
| 卷 84, 编号 5 (2012) |
Editorial |
SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION, ASSOCIATED WITH SYSTEMIC SCLEROSIS |
|
| 卷 90, 编号 4 (2018) |
Editorial |
Modern view on the place of riociguat in the treatment of pulmonary hypertension |
(Rus)
|
| 卷 90, 编号 4 (2018) |
Editorial |
New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension |
(Rus)
|
| 卷 91, 编号 1 (2019) |
Editorial |
Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry |
(Rus)
|
| 卷 90, 编号 9 (2018) |
Editorial |
The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation |
(Rus)
|
| 卷 91, 编号 3 (2019) |
Editorial |
Comparison of the integral indices of the vectorcardiogram with the data of echocardiography in patients with idiopathic and chronic thromboembolic pulmonary hypertension |
(Rus)
|
| 卷 91, 编号 3 (2019) |
Editorial |
Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension" |
(Rus)
|
| 卷 91, 编号 9 (2019) |
Editorial |
Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry |
(Rus)
|
| 卷 92, 编号 3 (2020) |
Original articles |
Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world |
(Rus)
|
| 卷 92, 编号 5 (2020) |
Consensuns |
Possibility of complex medicamental and endovascular treatment of pulmonary hypertension in Takayasu arteritis with predominant pulmonary arteries’ lesion |
(Rus)
|
| 卷 92, 编号 9 (2020) |
Reviews |
Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension |
(Rus)
|
| 卷 92, 编号 9 (2020) |
Reviews |
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat |
(Rus)
|
| 卷 94, 编号 4 (2022) |
Clinical notes |
A rare clinical case of the patient with pulmonary hypertension associated with hereditary hemorrhagic telangiectasia. Case report |
(Rus)
|
| 卷 93, 编号 3 (2021) |
Original articles |
Influence of demographic characteristics on the clinical course and results of therapy in patients with precapillary pulmonary hypertension |
(Rus)
|
| 卷 93, 编号 4 (2021) |
Original articles |
Impact of summer heat waves on key parameters of oxidative stress in patients with coronary artery disease |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Editorial |
Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Original articles |
Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry |
(Rus)
|
| 卷 93, 编号 9 (2021) |
Reviews |
Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat |
(Rus)
|
| 卷 94, 编号 7 (2022) |
Editorial |
Chronic thromboembolic pulmonary hypertension: from pathogenesis to the choice of treatment tactics |
(Rus)
|
| 卷 94, 编号 9 (2022) |
Consensuns |
"Guiding lights" for the diagnosis of chronic thromboembolic pulmonary hypertension in the flow of patients with pulmonary embolism |
(Rus)
|
| 卷 95, 编号 4 (2023) |
Editorial |
Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension |
(Rus)
|
